Anifrolumab, a potential new treatment for systemic lupus erythematosus (SLE), was given a second look in a clinical trial published in the New England Journal of Medicine this month. This time, the results look promising. Learn more about the trial in this slideshow.
REFERENCE: Eric F. Morand, M.B., B.S., Ph.D.; Richard Furie, M.D., Yoshiya Tanaka, M.D., Ph.D., et al. "Trial of Anifrolumab in Active Systemic Lupus Erythematosus," NEJM. Jan. 16, 2020. DOI: 10.1056/NEJMoa1912196